The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie’s disease
- 1 July 2008
- journal article
- clinical trial
- Published by Springer Nature in International Urology and Nephrology
- Vol. 41 (1) , 113-118
Abstract
To determine the effectiveness of transdermal electromotive administration (TEA) of verapamil and dexamethasone in the treatment of Peyronie’s disease (PD). Totally, 51 patients with PD were prospectively included in the study. All patients were evaluated by history, subjective score scales, physical examination, photographs, and penile USG, before and after therapy. All patients were treated with TEA of the combination of verapamil and dexamethasone. The treatment plan included a total of 20 sessions (at 3-day intervals for a period of 2 months), each with a duration of 20 min. At the end of the study, improvements in penile plaques, penile deviation, pain on erection, and erectile dysfunction were determined. The findings in 41 of the 51 patients were eligible to present. Median patient age was 52 years. Median duration of disease at presentation was 8 months. Remarkable reduction in palpable plaques and in penile angulation was observed in 10 patients (24%) and 11 (26%) patients, respectively. There were significant decreases in median plaque volume from 72 mm2 to 45 mm2 (P < 0.001), and in median penile angulation from 25º to 15º (P < 0.001). Impaired sexual activity and pain on erection had completely resolved in 11 (55%) patients and in 16 (80%), respectively. The results of our study have shown that TEA of the combination of verapamil and dexamethasone is a more effective therapy for improving subjective symptoms rather than objective symptoms. Therefore, we think that this treatment can be individualized according to the clinical features of PD patients.Keywords
This publication has 35 references indexed in Scilit:
- Transdermal Application of Verapamil Gel to the Penile Shaft Fails to Infiltrate the Tunica AlbugineaJournal of Urology, 2002
- Peyronie's disease cell culture models: phenotypic, genotypic and functional analysesInternational Journal Of Impotence Research, 2002
- A Retrospective Review of 307 Men With Peyronie’s DiseaseJournal of Urology, 2002
- Experience With Intraplaque Injection of Verapamil for Peyronie’s DiseaseJournal of Urology, 2002
- Peyronie's disease in men under age 40: characteristics and outcomeInternational Journal Of Impotence Research, 2001
- TREATMENT OF PEYRONIE'S DISEASE WITH INTRALESIONAL VERAPAMIL INJECTIONJournal of Urology, 1997
- Proposal: Trauma as the Cause of the Peyronie's LesionJournal of Urology, 1997
- Mechanisms by Which Fibrin and Fibronectin Appear in Healing WoundsJournal of Urology, 1997
- Mechanisms by Which Fibrin and Fibronectin Appear in Healing Wounds: Implications for Peyronie's DiseaseJournal of Urology, 1997
- Evaluation of Conservative Therapeutic Approaches to Peyronie’s Disease (Fibrotic Induration of the Penis)Urologia Internationalis, 1991